Side-by-side financials for ALLO and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALLO | ARGX |
|---|---|---|
| Market cap | - | $55.29 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$190.89M | - |
| SEC filings | 558 | 272 |
Full pages: Allogene Therapeutics, Inc. and ARGENX SE, or browse the full rankings.